Welcome to our dedicated page for Afya news (Ticker: AFYA), a resource for investors and traders seeking the latest updates and insights on Afya stock.
Afya Limited (AFYA) delivers essential medical education and digital health solutions across Brazil through its integrated network and technology platforms. This news hub provides investors and healthcare professionals with centralized access to corporate developments, strategic initiatives, and operational updates.
Track official press releases covering financial results, academic partnerships, technology implementations, and regulatory milestones. Our curated collection includes updates on Afya's three core segments: Undergraduate medical programs, Continuing Education certifications, and Digital Services supporting clinical decision-making.
Key updates feature expansion of educational partnerships, digital tool enhancements for healthcare providers, and growth metrics across Afya's learning platforms. Users benefit from chronological organization of material events and strategic announcements without editorial commentary.
Bookmark this page for streamlined monitoring of Afya's progress in merging traditional medical training with innovative digital solutions. Verify publication dates and consult original filings for complete context on all developments.
Afya Limited (NASDAQ: AFYA) announces the authorization of two new medical schools in Brazil under the Mais Médicos II program. The schools, located in Abaetetuba (Pará) and Itacoatiara (Amazonas), will each contribute 50 seats, increasing Afya's total operating seats to 2,581 out of 2,731 approved seats. This expansion marks a significant milestone for Afya, cementing its position as a leading medical education group in Brazil.
Afya Limited (NASDAQ: AFYA) has announced a new share repurchase program after successfully completing its previous one, which bought back 1,383,108 Class A common shares. The new program allows for the repurchase of up to 1,874,457 shares, equating to 4% of its free float, from January 27, 2022, to December 31, 2022. The shares will be purchased in the open market or via private transactions, depending on market conditions. These repurchases aim to support stock options, future business combinations, and general corporate purposes.
Afya Limited (NASDAQ: AFYA) announced that Júlio de Angeli, VP of Innovation & Digital Services, will leave the company at the end of January 2022. He will assist in transitioning his duties. Lélio de Souza has been appointed as the new VP of Digital Services Officer, effective immediately. He has a robust digital background, previously serving as CEO of Intelie and holding managerial positions at TOTVS and Accenture. Afya is a major medical education provider in Brazil, supporting medical students and professionals through various educational services and digital products.
Afya Limited (NASDAQ: AFYA) reported strong financial results for Q3 2021, with Adjusted Net Revenue rising 47.9% year-on-year to R$463.3 million and Adjusted EBITDA increasing 28.2% to R$191.4 million. The nine-month results showed a 45.1% growth in Adjusted Net Revenue to R$1,247.3 billion. Cash flow from operations surged 71.1% to R$528.7 million, achieving a cash conversion of 113.5%.
Afya's ecosystem now includes 247,000 physicians and medical students, indicating significant growth in their digital services.
Afya Limited (Nasdaq: AFYA) has received authorization from Brazil's Ministry of Education to operate a new medical school in Garanhuns, Pernambuco. This approval allows ITPAC, a subsidiary, to expand operations and provide 120 medical seats, translating to a purchase price of R$108 million, with half payable at closing and the remainder in two annual installments. This move aligns with Afya's goal of being a leading medical education provider in Brazil.
Afya Limited (NASDAQ: AFYA) is set to report its third quarter 2021 financial results for the period ending September 30, 2021, after market close on November 22, 2021. Following this, a conference call and webcast will be hosted at 5:00 PM EDT on the same day, allowing investors to gain insights into the company's performance. Investors can access the webcast live or in archive form on the company's Investor Relations website.
Afya Limited (NASDAQ: AFYA) announced a new share repurchase program allowing the purchase of up to 1,383,108 Class A common shares starting October 28, 2021, until December 31, 2022. This follows a previous program where 1,015,844 shares were repurchased. The initiative aims to utilize existing funds, and repurchases will be executed based on market conditions. Afya also appointed BofA Securities as the purchasing agent, adhering to SEC Rule 10b-18 to ensure compliance.
Afya Limited (NASDAQ: AFYA) has acquired 100% of RX PRO, a service facilitating connections between physicians and the pharmaceutical industry. RX PRO's innovative platform has reached over 45,000 physicians and is currently utilized by more than 12 pharmaceutical companies, forecasting a gross revenue of R$8.9 million for 2021. The acquisition cost R$35.4 million, with 85% paid in cash and the rest in Afya shares, plus an earn-out potential of R$21 million based on future revenue targets.
Afya Limited (Nasdaq: AFYA) reported robust financial results for Q2 and H1 2021, with adjusted net revenue of R$381.5 million, up 39.1% YoY, and R$784.0 million for H1, rising 43.5% YoY. Adjusted EBITDA also increased to R$160.7 million (42.1% margin) for Q2 and R$368.3 million (47.0% margin) for H1. However, adjusted net income fell 27.3% to R$65.1 million. Cash flow from operations surged 70.0% to R$343.2 million, aided by a strong cash position of R$1.4 billion. Afya continues its digital strategy with new acquisitions, targeting sustainable growth and increased market penetration.
FAQ
What is the current stock price of Afya (AFYA)?
What is the market cap of Afya (AFYA)?
